Interval debulking surgery in advanced epithelial ovarian cancer.

  title={Interval debulking surgery in advanced epithelial ovarian cancer.},
  author={Sergio L Pecorelli and Franco Edoardo Odicino and Giuseppe Favalli},
  journal={Best practice & research. Clinical obstetrics & gynaecology},
  volume={16 4},
Cytoreductive surgery and chemotherapy are the mainstay for the treatment of advanced epithelial ovarian cancer. In order to minimize the tumour burden before chemotherapy, cytoreductive surgery is usually performed first. The importance of the amount of residual disease as the main prognostic factor for patients suffering from advanced disease has been almost universally accepted even in the absence of prospective randomized trials addressing the benefit of cytoreductive surgery. In the last… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond

Springer Singapore • 2018
View 6 Excerpts
Highly Influenced

Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics • 2003

Similar Papers

Loading similar papers…